Hui‐Ling Chiou
Impact in
- Biochemistry top 1%
- Phytochemicals and Antioxidant Activities
- Cancer Research top 2%
- Protease and Inhibitor Mechanisms
- Cancer-related molecular mechanisms research
Papers in
-
- Enzyme function and inhibition 6
- Phytochemical compounds biological activities 5
- Oncology 25
- Peptidase Inhibition and Analysis 10
- Cancer-related Molecular Pathways 5
- Co-authors
- Shun‐Fa Yang (59 shared papers)Shu‐Chen Chu (9 shared papers)Pei‐Ni Chen (7 shared papers)Yih‐Shou Hsieh (14 shared papers)Chui-Liang Chiang (3 shared papers)Ming‐Ju Hsieh (15 shared papers)Wu‐Hsien Kuo (4 shared papers)Yih‐Shou Hsieh (4 shared papers)
- Journals
- Clinica Chimica Acta (6 papers)Environmental Toxicology (4 papers)Cancer Letters (4 papers)Oncotarget (4 papers)Oral Oncology (3 papers)
- Partner nations
- TaiwanUnited StatesCzechia
In The Last Decade
Hui‐Ling Chiou
93 papers receiving 3.7k citations
Peers
Comparison fields: 5 of 124
- Biochemistry 441
- Cancer Research 701
- Pharmacology 274
- Molecular Biology 1.9k
- Complementary and alternative medicine 188
Countries citing papers authored by Hui‐Ling Chiou
This map shows the geographic impact of Hui‐Ling Chiou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui‐Ling Chiou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui‐Ling Chiou more than expected).
Fields of papers citing papers by Hui‐Ling Chiou
This network shows the impact of papers produced by Hui‐Ling Chiou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui‐Ling Chiou. The network helps show where Hui‐Ling Chiou may publish in the future.
Co-authors
The 25 scholars most cited alongside Hui‐Ling Chiou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 349 | |
| 2 | 2005 | 219 | |
| 3 | 2006 | 193 | |
| 4 | 2005 | 166 | |
| 5 | 2004 | 151 | |
| 6 | 2007 | 112 | |
| 7 | 2013 | 99 | |
| 8 | 2006 | 90 | |
| 9 | 2010 | 90 | |
| 10 | 2017 | 85 | |
| 11 | 2014 | 78 | |
| 12 | 2003 | 71 | |
| 13 | 2005 | 70 | |
| 14 | 2016 | 62 | |
| 15 | 2017 | 62 | |
| 16 | 2007 | 56 | |
| 17 | 2015 | 55 | |
| 18 | 2019 | 55 | |
| 19 | 2004 | 55 | |
| 20 | 2006 | 54 |
About Hui‐Ling Chiou
Hui‐Ling Chiou is a scholar working on Molecular Biology, Oncology, Cancer Research, Epidemiology and Immunology, having authored 94 papers that have together received 3.8k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (12 papers), Peptidase Inhibition and Analysis (10 papers), Autophagy in Disease and Therapy (7 papers), Enzyme function and inhibition (6 papers), Phytochemical compounds biological activities (5 papers), Liver Disease Diagnosis and Treatment (5 papers), Pharmacological Effects of Natural Compounds (5 papers) and Cancer-related Molecular Pathways (5 papers). The work is most often cited by research in Biochemistry (441 citations), Cancer Research (701 citations), Pharmacology (274 citations), Molecular Biology (1.9k citations) and Complementary and alternative medicine (188 citations). Hui‐Ling Chiou has collaborated with scholars based in Taiwan, United States and Czechia. Frequent co-authors include Shun‐Fa Yang, Shu‐Chen Chu, Pei‐Ni Chen, Yih‐Shou Hsieh, Chui-Liang Chiang, Ming‐Ju Hsieh, Wu‐Hsien Kuo, Yih‐Shou Hsieh, Yi‐Hsien Hsieh and Mu‐Kuan Chen. Their work appears in journals such as Clinica Chimica Acta, Environmental Toxicology, Cancer Letters, Oncotarget and Oral Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.